Technical Analysis for XRTX - XORTX Therapeutics Inc.

Grade Last Price % Change Price Change
D 2.89 -4.30% -0.13
XRTX closed down 4.3 percent on Monday, October 18, 2021, on 78 percent of normal volume. The bears made the stock sink to a new 52-week low.
Earnings due: Oct 19
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical XRTX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
New 52 Week Closing Low Bearish -4.30%
Hot IPO Pullback Bullish Swing Setup -4.30%
New 52 Week Low Weakness -4.30%
New 52 Week Closing High Bullish -9.12%
Older End-of-Day Signals for XRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


XORTX Therapeutics Inc. is a pharmaceutical company with two clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection and XRx-225 is a pre-clinical stage program for Type 2 Diabetic Nephropathy (T2DN). XORTX is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.

Sector: Technology
Industry: Data Storage Devices
Keywords: Pharmaceutical Organ Systems Infection Kidney Disease Kidney Diseases Diabetic Nephropathy Kidney Autosomal Dominant Polycystic Kidney Disease

Is XRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.48
52 Week Low 2.84
Average Volume 148,596
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.36
Resistance 3 (R3) 3.39 3.27 3.28
Resistance 2 (R2) 3.27 3.15 3.25 3.25
Resistance 1 (R1) 3.08 3.08 3.02 3.05 3.23
Pivot Point 2.96 2.96 2.93 2.94 2.96
Support 1 (S1) 2.77 2.84 2.71 2.74 2.55
Support 2 (S2) 2.65 2.77 2.63 2.53
Support 3 (S3) 2.46 2.65 2.50
Support 4 (S4) 2.43